The Marker-נבחרת הסטארטאפים 2020
Hillel’s Tech Corner: CytoReason: Where AI meets drug development
How to fight infection by turning back your immune system’s clock
AI for Drug Discovery, Biomarker Development and Advanced R&D Landscape Overview 2019 / q3
A space odyssey for new antibiotics
Companies Applying Artificial Intelligence In Drug Discovery and Development
Can AI reveal complex patterns in biological data?
Israel’s R&D Prowess Is Fueling Pharmaceutical Innovation
Pharma companies slow to adopt AI will be ‘left behind’
Escaping the Pre-Clinical Mousetrap – Machine Learning from Humans to Cure in Humans
